Administer intravenously 25 mcg/kg within 5 minutes and then 0.15 mcg/kg/min (or 0.075 mcg/kg/min for   patients with creatinine clearance â‰¤60 mL/min), for up to 18 hours. This is not the regimen that was used   in studies that established effectiveness of AGGRASTAT [see Clinical Studies].
The instructions by weight and creatinine clearance (CrCl) are tabulated in Table 1.
Table 1 Dos ing by Weight and CrCl 
